Table 1.
Clinicopathological variables for the metastatic colorectal cancer cohort (n = 30).
| Clinicopathological Variables | n (%) |
|---|---|
| Age | |
| Median | 53.0 |
| Range | 32–82 |
| ≤50 years | 13 (43.3) |
| >50 years | 17 (56.7) |
| Sex | |
| Male | 13 (43.3) |
| Female | 17 (56.7) |
| Histopathology | |
| Adenocarcinoma | 29 (96.7) |
| Mucinous carcinoma | 1 (3.3) |
| Tumour Site | |
| Right colon | 6 (20.0) |
| Left colon and rectum | 24 (80.0) |
| Histologic Grade | |
| Well differentiated | 4 (13.3) |
| Moderately differentiated | 24 (80.0) |
| Poorly differentiated | 2 (6.7) |
| pT | |
| T1 | 0 (0.0) |
| T2 | 1 (3.3) |
| T3 | 20 (66.7) |
| T4 | 9 (30.0) |
| pN | |
| N0 | 5 (16.7) |
| N1 | 14 (46.6) |
| N2 | 11 (36.7) |
| Microsatellite Instability | |
| Microsatellite instable (MSI) | 0 (0.0) |
| Microsatellite stable (MSS) | 30 (100.0) |
| Site of Distant Metastasis | |
| Liver | 18 (60.0) |
| Lung | 3 (10.0) |
| Ovary | 4 (13.3) |
| Urinary Bladder | 2 (6.7) |
| Spleen | 1 (3.3) |
| Adrenal gland | 1 (3.3) |
| Prostate | 1 (3.3) |
| Treated Primary Tumour | |
| No | 19 (63.3) |
| Yes | 10 (33.3) |
| Unknown | 1 (3.3) |
| Treated Distant Metastatic Tumour | |
| No | 16 (53.3) |
| Yes | 14 (46.7) |
| Unknown | 0 (0.0) |